Galanin-acetylcholine interactions: Relevance to memory and Alzheimer's disease

被引:109
作者
Crawley, JN
机构
关键词
galanin; neuropeptide; acetylcholine; neurotransmitter release; learning and memory; Alzheimer's disease;
D O I
10.1016/0024-3205(96)00093-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The neuropeptide, galanin, and its receptors are localized in the cholinergic basal forebrain and its projection areas in mammalian brain. Centrally administered galanin inhibits acetylcholine release in the rat ventral hippocampus, and produces deficits in learning and memory tasks. In Alzheimer's disease, galanin is overexpressed in terminals innervating the nucleus basalis of Meynert cell bodies. Selective galanin receptor antagonists provide a novel approach for increasing cholinergic function, as a potential adjunct to the clinical treatment of dementias.
引用
收藏
页码:2185 / 2199
页数:15
相关论文
共 112 条
  • [1] SELECTIVE UP-REGULATION OF NEUROPEPTIDE SYNTHESIS BY BLOCKING THE NEURONAL-ACTIVITY - GALANIN EXPRESSION IN SEPTOHIPPOCAMPAL NEURONS
    AGOSTON, DV
    KOMOLY, S
    PALKOVITS, M
    [J]. EXPERIMENTAL NEUROLOGY, 1994, 126 (02) : 247 - 255
  • [2] DOES GALANIN INHIBIT INSULIN-SECRETION BY OPENING OF THE ATP-REGULATED K+ CHANNEL IN THE BETA-CELL
    AHREN, B
    BERGGREN, PO
    BOKVIST, K
    RORSMAN, P
    [J]. PEPTIDES, 1989, 10 (02) : 453 - 457
  • [3] MECHANISM OF GALANIN-INHIBITED INSULIN RELEASE - OCCURRENCE OF A PERTUSSIS-TOXIN-SENSITIVE INHIBITION OF ADENYLATE-CYCLASE
    AMIRANOFF, B
    LORINET, AM
    LAGNYPOURMIR, I
    LABURTHE, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 177 (01): : 147 - 152
  • [4] MECHANISM OF THE GALANIN INDUCED INCREASE IN ACETYLCHOLINE-RELEASE INVIVO FROM STRIATA OF FREELY MOVING RATS
    AMOROSO, D
    GIROTTI, P
    FISONE, G
    BARTFAI, T
    CONSOLO, S
    [J]. BRAIN RESEARCH, 1992, 589 (01) : 33 - 38
  • [5] Asan E., 1990, DEMENTIA, V1, P18, DOI 10.1159/000107116
  • [6] GALANIN AND GALANIN ANTAGONISTS - MOLECULAR AND BIOCHEMICAL PERSPECTIVES
    BARTFAI, T
    FISONE, G
    LANGEL, U
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) : 312 - 317
  • [7] GALANIN-RECEPTOR LIGAND M40 PEPTIDE DISTINGUISHES BETWEEN PUTATIVE GALANIN-RECEPTOR SUBTYPES
    BARTFAI, T
    LANGEL, U
    BEDECS, K
    ANDELL, S
    LAND, T
    GREGERSEN, S
    AHREN, B
    GIROTTI, P
    CONSOLO, S
    CORWIN, R
    CRAWLEY, J
    XU, XJ
    WIESENFELDHALLIN, Z
    HOKFELT, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) : 11287 - 11291
  • [8] M-15 - HIGH-AFFINITY CHIMERIC PEPTIDE THAT BLOCKS THE NEURONAL ACTIONS OF GALANIN IN THE HIPPOCAMPUS, LOCUS-CERULEUS, AND SPINAL-CORD
    BARTFAI, T
    BEDECS, K
    LAND, T
    LANGEL, U
    BERTORELLI, R
    GIROTTI, P
    CONSOLO, S
    XU, XJ
    WIESENFELDHALLIN, Z
    NILSSON, S
    PIERIBONE, VA
    HOKFELT, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10961 - 10965
  • [9] GALANIN IMMUNOREACTIVITY IS INCREASED IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE
    BEAL, MF
    MACGARVEY, U
    SWARTZ, KJ
    [J]. ANNALS OF NEUROLOGY, 1990, 28 (02) : 157 - 161
  • [10] GALANIN-LIKE IMMUNOREACTIVITY IS UNCHANGED IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE DEMENTIA CEREBRAL-CORTEX
    BEAL, MF
    CLEVENS, RA
    CHATTHA, GK
    MACGARVEY, UM
    MAZUREK, MF
    GABRIEL, SM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) : 1935 - 1941